UK cost agency questions benefits of Sanofi MS pill
LONDON (Reuters) - Britain's healthcare cost watchdog wants more information from Sanofi on the effectiveness of its new multiple sclerosis pill Aubag...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/YQdWtT0SK3s/story01.htm
No comments:
Post a Comment